Global and United States Implantable and Needle-Free Drug Delivery Market Report & Forecast 2023-2028

Report ID: 1825527 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Implantable and Needle-Free Drug Delivery Revenue in Implantable and Needle-Free Drug Delivery Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Implantable and Needle-Free Drug Delivery Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Implantable and Needle-Free Drug Delivery Market Size for the Year 2017-2028
        1.2.2 Global Implantable and Needle-Free Drug Delivery Market Size for the Year 2017-2028
    1.3 Implantable and Needle-Free Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Implantable and Needle-Free Drug Delivery in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Implantable and Needle-Free Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Implantable and Needle-Free Drug Delivery Market Dynamics
        1.4.1 Implantable and Needle-Free Drug Delivery Industry Trends
        1.4.2 Implantable and Needle-Free Drug Delivery Market Drivers
        1.4.3 Implantable and Needle-Free Drug Delivery Market Challenges
        1.4.4 Implantable and Needle-Free Drug Delivery Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Implantable and Needle-Free Drug Delivery by Type
    2.1 Implantable and Needle-Free Drug Delivery Market Segment by Type
        2.1.1 Implantable Drug Delivery
        2.1.2 Needle-Free Drug Delivery
    2.2 Global Implantable and Needle-Free Drug Delivery Market Size by Type (2017, 2022 & 2028)
    2.3 Global Implantable and Needle-Free Drug Delivery Market Size by Type (2017-2028)
    2.4 United States Implantable and Needle-Free Drug Delivery Market Size by Type (2017, 2022 & 2028)
    2.5 United States Implantable and Needle-Free Drug Delivery Market Size by Type (2017-2028)
3 Implantable and Needle-Free Drug Delivery by Application
    3.1 Implantable and Needle-Free Drug Delivery Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Others
    3.2 Global Implantable and Needle-Free Drug Delivery Market Size by Application (2017, 2022 & 2028)
    3.3 Global Implantable and Needle-Free Drug Delivery Market Size by Application (2017-2028)
    3.4 United States Implantable and Needle-Free Drug Delivery Market Size by Application (2017, 2022 & 2028)
    3.5 United States Implantable and Needle-Free Drug Delivery Market Size by Application (2017-2028)
4 Global Implantable and Needle-Free Drug Delivery Competitor Landscape by Company
    4.1 Global Implantable and Needle-Free Drug Delivery Market Size by Company
        4.1.1 Top Global Implantable and Needle-Free Drug Delivery Companies Ranked by Revenue (2021)
        4.1.2 Global Implantable and Needle-Free Drug Delivery Revenue by Player (2017-2022)
    4.2 Global Implantable and Needle-Free Drug Delivery Concentration Ratio (CR)
        4.2.1 Implantable and Needle-Free Drug Delivery Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Implantable and Needle-Free Drug Delivery in 2021
        4.2.3 Global Implantable and Needle-Free Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Implantable and Needle-Free Drug Delivery Headquarters, Revenue in Implantable and Needle-Free Drug Delivery Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Implantable and Needle-Free Drug Delivery Headquarters and Area Served
        4.3.2 Global Implantable and Needle-Free Drug Delivery Companies Revenue in Implantable and Needle-Free Drug Delivery Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Implantable and Needle-Free Drug Delivery Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Implantable and Needle-Free Drug Delivery Market Size by Company
        4.5.1 Top Implantable and Needle-Free Drug Delivery Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Implantable and Needle-Free Drug Delivery Revenue by Players (2020, 2021 & 2022)
5 Global Implantable and Needle-Free Drug Delivery Market Size by Region
    5.1 Global Implantable and Needle-Free Drug Delivery Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Implantable and Needle-Free Drug Delivery Market Size by Region (2017-2028)
        5.2.1 Global Implantable and Needle-Free Drug Delivery Market Size by Region: 2017-2022
        5.2.2 Global Implantable and Needle-Free Drug Delivery Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Implantable and Needle-Free Drug Delivery Market Size YoY Growth 2017-2028
        6.1.2 North America Implantable and Needle-Free Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Implantable and Needle-Free Drug Delivery Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Implantable and Needle-Free Drug Delivery Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Implantable and Needle-Free Drug Delivery Market Size YoY Growth 2017-2028
        6.3.2 Europe Implantable and Needle-Free Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Implantable and Needle-Free Drug Delivery Market Size YoY Growth 2017-2028
        6.4.2 Latin America Implantable and Needle-Free Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Implantable and Needle-Free Drug Delivery Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Implantable and Needle-Free Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Boston Scientific
        7.1.1 Boston Scientific Company Details
        7.1.2 Boston Scientific Business Overview
        7.1.3 Boston Scientific Implantable and Needle-Free Drug Delivery Introduction
        7.1.4 Boston Scientific Revenue in Implantable and Needle-Free Drug Delivery Business (2017-2022)
        7.1.5 Boston Scientific Recent Development
    7.2 Bayer
        7.2.1 Bayer Company Details
        7.2.2 Bayer Business Overview
        7.2.3 Bayer Implantable and Needle-Free Drug Delivery Introduction
        7.2.4 Bayer Revenue in Implantable and Needle-Free Drug Delivery Business (2017-2022)
        7.2.5 Bayer Recent Development
    7.3 Medtronic
        7.3.1 Medtronic Company Details
        7.3.2 Medtronic Business Overview
        7.3.3 Medtronic Implantable and Needle-Free Drug Delivery Introduction
        7.3.4 Medtronic Revenue in Implantable and Needle-Free Drug Delivery Business (2017-2022)
        7.3.5 Medtronic Recent Development
    7.4 Pharmajet
        7.4.1 Pharmajet Company Details
        7.4.2 Pharmajet Business Overview
        7.4.3 Pharmajet Implantable and Needle-Free Drug Delivery Introduction
        7.4.4 Pharmajet Revenue in Implantable and Needle-Free Drug Delivery Business (2017-2022)
        7.4.5 Pharmajet Recent Development
    7.5 Crossject
        7.5.1 Crossject Company Details
        7.5.2 Crossject Business Overview
        7.5.3 Crossject Implantable and Needle-Free Drug Delivery Introduction
        7.5.4 Crossject Revenue in Implantable and Needle-Free Drug Delivery Business (2017-2022)
        7.5.5 Crossject Recent Development
    7.6 BD
        7.6.1 BD Company Details
        7.6.2 BD Business Overview
        7.6.3 BD Implantable and Needle-Free Drug Delivery Introduction
        7.6.4 BD Revenue in Implantable and Needle-Free Drug Delivery Business (2017-2022)
        7.6.5 BD Recent Development
    7.7 Mystic Pharmaceuticals
        7.7.1 Mystic Pharmaceuticals Company Details
        7.7.2 Mystic Pharmaceuticals Business Overview
        7.7.3 Mystic Pharmaceuticals Implantable and Needle-Free Drug Delivery Introduction
        7.7.4 Mystic Pharmaceuticals Revenue in Implantable and Needle-Free Drug Delivery Business (2017-2022)
        7.7.5 Mystic Pharmaceuticals Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Implantable and Needle-Free Drug Delivery Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Implantable and Needle-Free Drug Delivery Market Trends
    Table 3. Implantable and Needle-Free Drug Delivery Market Drivers
    Table 4. Implantable and Needle-Free Drug Delivery Market Challenges
    Table 5. Implantable and Needle-Free Drug Delivery Market Restraints
    Table 6. Global Implantable and Needle-Free Drug Delivery Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Implantable and Needle-Free Drug Delivery Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Implantable and Needle-Free Drug Delivery Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Implantable and Needle-Free Drug Delivery Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Implantable and Needle-Free Drug Delivery Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Implantable and Needle-Free Drug Delivery Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Implantable and Needle-Free Drug Delivery Revenue Share by Player, 2017-2022
    Table 13. Global Implantable and Needle-Free Drug Delivery Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Implantable and Needle-Free Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable and Needle-Free Drug Delivery as of 2021)
    Table 15. Top Players of Implantable and Needle-Free Drug Delivery in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Implantable and Needle-Free Drug Delivery Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Implantable and Needle-Free Drug Delivery Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Implantable and Needle-Free Drug Delivery Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Implantable and Needle-Free Drug Delivery Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Implantable and Needle-Free Drug Delivery Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Implantable and Needle-Free Drug Delivery Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Implantable and Needle-Free Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Implantable and Needle-Free Drug Delivery Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Implantable and Needle-Free Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Implantable and Needle-Free Drug Delivery Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Implantable and Needle-Free Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Implantable and Needle-Free Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Implantable and Needle-Free Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Boston Scientific Company Details
    Table 31. Boston Scientific Business Overview
    Table 32. Boston Scientific Implantable and Needle-Free Drug Delivery Product
    Table 33. Boston Scientific Revenue in Implantable and Needle-Free Drug Delivery Business (2017-2022) & (US$ Million)
    Table 34. Boston Scientific Recent Development
    Table 35. Bayer Company Details
    Table 36. Bayer Business Overview
    Table 37. Bayer Implantable and Needle-Free Drug Delivery Product
    Table 38. Bayer Revenue in Implantable and Needle-Free Drug Delivery Business (2017-2022) & (US$ Million)
    Table 39. Bayer Recent Development
    Table 40. Medtronic Company Details
    Table 41. Medtronic Business Overview
    Table 42. Medtronic Implantable and Needle-Free Drug Delivery Product
    Table 43. Medtronic Revenue in Implantable and Needle-Free Drug Delivery Business (2017-2022) & (US$ Million)
    Table 44. Medtronic Recent Development
    Table 45. Pharmajet Company Details
    Table 46. Pharmajet Business Overview
    Table 47. Pharmajet Implantable and Needle-Free Drug Delivery Product
    Table 48. Pharmajet Revenue in Implantable and Needle-Free Drug Delivery Business (2017-2022) & (US$ Million)
    Table 49. Pharmajet Recent Development
    Table 50. Crossject Company Details
    Table 51. Crossject Business Overview
    Table 52. Crossject Implantable and Needle-Free Drug Delivery Product
    Table 53. Crossject Revenue in Implantable and Needle-Free Drug Delivery Business (2017-2022) & (US$ Million)
    Table 54. Crossject Recent Development
    Table 55. BD Company Details
    Table 56. BD Business Overview
    Table 57. BD Implantable and Needle-Free Drug Delivery Product
    Table 58. BD Revenue in Implantable and Needle-Free Drug Delivery Business (2017-2022) & (US$ Million)
    Table 59. BD Recent Development
    Table 60. Mystic Pharmaceuticals Company Details
    Table 61. Mystic Pharmaceuticals Business Overview
    Table 62. Mystic Pharmaceuticals Implantable and Needle-Free Drug Delivery Product
    Table 63. Mystic Pharmaceuticals Revenue in Implantable and Needle-Free Drug Delivery Business (2017-2022) & (US$ Million)
    Table 64. Mystic Pharmaceuticals Recent Development
    Table 65. Research Programs/Design for This Report
    Table 66. Key Data Information from Secondary Sources
    Table 67. Key Data Information from Primary Sources
List of Figures
    Figure 1. Implantable and Needle-Free Drug Delivery Product Picture
    Figure 2. Global Implantable and Needle-Free Drug Delivery Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Implantable and Needle-Free Drug Delivery Market Size 2017-2028 (US$ Million)
    Figure 4. United States Implantable and Needle-Free Drug Delivery Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Implantable and Needle-Free Drug Delivery Market Size 2017-2028 (US$ Million)
    Figure 6. United States Implantable and Needle-Free Drug Delivery Market Share in Global 2017-2028
    Figure 7. Implantable and Needle-Free Drug Delivery Report Years Considered
    Figure 8. Product Picture of Implantable Drug Delivery
    Figure 9. Product Picture of Needle-Free Drug Delivery
    Figure 10. Global Implantable and Needle-Free Drug Delivery Market Share by Type in 2022 & 2028
    Figure 11. Global Implantable and Needle-Free Drug Delivery Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Implantable and Needle-Free Drug Delivery Market Share by Type (2017-2028)
    Figure 13. United States Implantable and Needle-Free Drug Delivery Market Share by Type in 2022 & 2028
    Figure 14. United States Implantable and Needle-Free Drug Delivery Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Implantable and Needle-Free Drug Delivery Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of Clinics
    Figure 18. Product Picture of Others
    Figure 19. Global Implantable and Needle-Free Drug Delivery Market Share by Application in 2022 & 2028
    Figure 20. Global Implantable and Needle-Free Drug Delivery Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Implantable and Needle-Free Drug Delivery Market Share by Application (2017-2028)
    Figure 22. United States Implantable and Needle-Free Drug Delivery Market Share by Application in 2022 & 2028
    Figure 23. United States Implantable and Needle-Free Drug Delivery Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Implantable and Needle-Free Drug Delivery Market Share by Application (2017-2028)
    Figure 25. North America Implantable and Needle-Free Drug Delivery Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Implantable and Needle-Free Drug Delivery Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Implantable and Needle-Free Drug Delivery Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Implantable and Needle-Free Drug Delivery Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Implantable and Needle-Free Drug Delivery Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.A.E Implantable and Needle-Free Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Boston Scientific Revenue Growth Rate in Implantable and Needle-Free Drug Delivery Business (2017-2022)
    Figure 54. Bayer Revenue Growth Rate in Implantable and Needle-Free Drug Delivery Business (2017-2022)
    Figure 55. Medtronic Revenue Growth Rate in Implantable and Needle-Free Drug Delivery Business (2017-2022)
    Figure 56. Pharmajet Revenue Growth Rate in Implantable and Needle-Free Drug Delivery Business (2017-2022)
    Figure 57. Crossject Revenue Growth Rate in Implantable and Needle-Free Drug Delivery Business (2017-2022)
    Figure 58. BD Revenue Growth Rate in Implantable and Needle-Free Drug Delivery Business (2017-2022)
    Figure 59. Mystic Pharmaceuticals Revenue Growth Rate in Implantable and Needle-Free Drug Delivery Business (2017-2022)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Boston Scientific
Bayer
Medtronic
Pharmajet
Crossject
BD
Mystic Pharmaceuticals
Frequently Asked Questions
Implantable and Needle-Free Drug Delivery report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Implantable and Needle-Free Drug Delivery report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Implantable and Needle-Free Drug Delivery report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports